Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Queensland Health
Express Scripts
Accenture
Teva
Deloitte
Boehringer Ingelheim
Healthtrust
Dow
Mallinckrodt

Generated: February 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 088815

« Back to Dashboard

NDA 088815 describes PROMETHAZINE VC PLAIN, which is a drug marketed by Cenci and Wockhardt and is included in two NDAs. Additional details are available on the PROMETHAZINE VC PLAIN profile page.

The generic ingredient in PROMETHAZINE VC PLAIN is phenylephrine hydrochloride; promethazine hydrochloride. There are twenty drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the phenylephrine hydrochloride; promethazine hydrochloride profile page.
Summary for 088815
Tradename:PROMETHAZINE VC PLAIN
Applicant:Cenci
Ingredient:phenylephrine hydrochloride; promethazine hydrochloride
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SYRUP;ORALStrength5MG/5ML;6.25MG/5ML
Approval Date:Nov 22, 1985TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Chinese Patent Office
Julphar
Johnson and Johnson
Mallinckrodt
Express Scripts
Merck
McKinsey
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot